Fusion versus decompression alone for single-level lumbar stenosis
Official title: Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis: Study Protocol for an Open-label Multicenter Non-inferiority Randomized Controlled Clinical Trial
Run by Sklifosovsky Institute of Emergency Care · NCT05273879 · Data updated 2026-11-12
This trial will test whether decompression surgery without added fusion works as well as decompression plus fusion for adults aged 45–75 with single-level lumbar spinal stenosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 75 Years |
| Sex | All |
| Enrollment | 86 (estimated) |
| Sponsor | Sklifosovsky Institute of Emergency Care Government |
| Locations | 2 sites (Moscow, Moscow and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2022 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | December 18, 2025 |
| Trial ID | NCT05273879 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45–75 with single‑level (L2–S1) lumbar stenosis grade C or D on MRI, symptomatic neurogenic claudication or radiculopathy, failure of ≥3 months of conservative care, no prior spine surgery, and acceptable bone density and stability are ideal candidates.
✕Probably not a fit
Patients with multilevel clinically significant stenosis, prior spine surgery, spinal instability or spondylolisthesis >3 mm, significant sagittal imbalance, very low bone density (<100 HU), or ASA class 4–5 are unlikely to benefit from this comparison or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial will enroll 86 adults with single‑level lumbar stenosis and assign them 1:1 to decompression that preserves posterior elements or to decompression plus transforaminal interbody fusion. Surgeons will use a standardized operative protocol and postoperative rehabilitation to maximize homogeneity between groups. The primary outcome is change in the Oswestry Disability Index at 24 months, and secondary outcomes include SF‑36, EQ‑5D‑5L, psychological scales, sagittal balance, fusion status, and total cost over two years. Patients will be followed at 3, 6, 12, and 24 months to capture clinical, radiographic, and economic outcomes.
Why it matters
Potential benefit: If decompression alone proves non‑inferior, many patients could avoid fusion, reducing surgical risk, implant-related complications, and cost.
How similar studies have gone: Only one randomized trial about 15 years ago directly addressed this question, so randomized evidence is limited and the necessity of fusion remains controversial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age of patients from 45 to 75 years; * stenosis C or D according to Shizas et al. according to MRI at the level of L2-L3, L3-L4, L4-L5 or L5-S1; * clinical manifestations of lumbar stenosis (neurogenic claudication syndrome and/or radiculopathy); * lack of effect from conservative therapy within 3 months; * Informed consent to take part in the study. Exclusion Criteria: * spondylolisthesis more than 3 mm; * spinal instability according to functional radiography; * sagittal imbalance (type 4 according to C. Barrey); * bone density of the vertebrae at the level of the operation is less than 100 HU; * clinically significant spinal stenosis at 2 or more levels; * previously performed surgeries on the spine; * risk of anesthesia 4 or 5 according to ASA; * inability to take part in control examinations within 2 years after the operation; * participation in other clinical trials related to surgical or conservative treatment of diseases of the spine.
Where it's running
-
Pirogov National Medical and Surgical Center
Moscow, Moscow, Russia Recruiting -
Sklifosovsky Research Institute for Emergency Medicine
Moscow, Moscow, Russia Recruiting
Study contacts
- Study coordinator: Ivan Lvov, MD, PhD
- Email: dr.speleolog@gmail.com
- Phone: +79265760074
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Modulating pulse-width during spinal surgery
This study is testing how different settings of electrical stimulation during spinal surgery can affect the safety and effectiveness of the procedure for patients.
-
Registry for patients with personalized spine rods
This study is testing whether personalized spine rods can help patients who have had spinal surgery feel better and have fewer problems compared to those with standard rods.
-
Using vancomycin powder with bone graft to prevent infections after spine surgery
This study is testing if using vancomycin powder with bone grafts can help prevent infections after spine surgery for patients who haven't found relief from other treatments.
-
Effect of Irrigation Pressure on Postoperative Complications and Surgical Field Clarity in Unilateral Biportal Endoscopic Spine Surgery
This study tests whether the height of the irrigation fluid bag and the direction of the surgical cut affect fluid pressure, visibility, and early recovery in adults undergoing unilateral biportal endoscopic spine surgery.
-
Blood Transfusion Factors and Cell Saver Use in Kids’ Spine Surgery
This study looks at which factors put pediatric scoliosis patients at risk for needing donor blood during posterior spinal fusion and how using a Cell Saver during surgery might reduce that need.
-
Microdecompression alone vs. decompression with fusion in adjacent segment stenosis
This trial tests whether a less invasive microdecompression can work as well as adding a fusion extension for people with adjacent segment stenosis after prior lumbar fusion.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.